Schedule 13G ownership disclosure

CARA THERAPEUTICS INC

Common Stock, par value $0.001 per share · CUSIP: 140755208

Event date: 2025-07-07

Filing-level shares
315,658.00
Percent of class
3.4%
  • Samuel D. Tweardy

    Shares: 315,658.00 · Class: 3.4%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001415889-25-021104
Form type
SCHEDULE 13G/A
Filer
Tvardi Therapeutics, Inc.
CIK
CIK 1346830
Filed
Aug 05, 2025
Reporting period
Jul 07, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub